Shanghai Runda Medical Technology Co., Ltd.

Shanghai Stock Exchange 603108.SS

Shanghai Runda Medical Technology Co., Ltd. Receivables for the year ending December 31, 2023: USD 832.88 M

Shanghai Runda Medical Technology Co., Ltd. Receivables is USD 832.88 M for the year ending December 31, 2023, a -8.48% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Shanghai Runda Medical Technology Co., Ltd. Receivables for the year ending December 31, 2022 was USD 910.06 M, a 34.74% change year over year.
Shanghai Runda Medical Technology Co., Ltd. Receivables for the year ending December 31, 2021 was USD 675.43 M, a 26.62% change year over year.
Shanghai Runda Medical Technology Co., Ltd. Receivables for the year ending December 31, 2020 was USD 533.42 M, a 20.40% change year over year.
Shanghai Runda Medical Technology Co., Ltd. Receivables for the year ending December 31, 2019 was USD 443.06 M, a 25.06% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Shanghai Stock Exchange: 603108.SS

Shanghai Runda Medical Technology Co., Ltd.

CEO	Mr. Cheng Xu Zhang
IPO Date	May 27, 2015
Location	China
Headquarters	Xinghui (Landmark) Center
Employees	3,315
Sector	Health Care
Industries Medical Instruments Biotechnology Hospitals & Clinics Pharmaceuticals

Description

Shanghai Runda Medical Technology Co., Ltd. provides integrated medical laboratory services in China. It offers platform supply, laboratory design/renovation, laboratory standardization, and information management system services; medical solutions to help healthcare professionals in the areas of biochemistry, diabetes, POCT, immunoassay analyzer, and molecular biology diagnosis; professional technical services; and logistic services. The company was founded in 1999 and is based in Shanghai, China.

Key trends

Past 5 years